InvestSMART

Epsilon Healthcare Limited (ASX:EPN)

ALERT: Price-sensitive ASX Announcement for EPN
Current share price for EPN : $0.023 0.003 (15%)+
Announcement
Release
30 Apr 2026 9:36AM
Price at Release
$0.020
Full Release
download
Summary
Epsilon Healthcare Limited reported a significant increase in its financial performance for the quarter ended March 31, 2026, with record customer receipts of $3.14 million, marking a 154% improvement from the same quarter in 2025. The company’s diversified operations, including Epsilon Pharma and Epsilon Pharmacy, contributed to this growth, with the latter achieving $2.3 million in annualised revenue within its first year of operation. Epsilon continues to expand its integrated healthcare platform through strategic investments in digital infrastructure and the opening of new facilities, such as a community pharmacy in Sydney. The company maintains a robust balance sheet with available cash of $503,000 and various financing facilities to support further expansion and resilience against market fluctuations.
Key Points
  • Epsilon Healthcare Limited reported record quarterly receipts of $3.14 million for the March 2026 quarter, a 154% increase from the previous year.
  • The company achieved consolidated revenue of $3.29 million, representing a 158% increase on the prior corresponding period.
  • Epsilon Pharma, the company's CDMO, experienced a year-on-year growth of 149% due to expanding manufacturing activities.
  • Epsilon Pharmacy, established 12 months ago, now boasts $2.3 million in annualised revenue.
  • The company’s financial position includes cash and cash equivalents of $503,000 at the end of the quarter.
  • The company has strengthened its balance sheet with a variety of financing options, including loans from related parties and secured facilities.
  • Epsilon Clinics maintained strong performance with recurring revenue and expansion in patient-centric care.
  • The company's integrated healthcare and manufacturing platform continues to scale, with a focus on digital infrastructure and physical expansion.
  • Epsilon is investing in digital infrastructure and planning to open its first full-line bricks-and-mortar community pharmacy in Sydney.
  • The company is poised to continue its growth trajectory, focusing on operational leverage and international market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.